Two Romanian men arrested in London for attacking British-Iranian journalist - Global Banking & Finance Review
The image depicts the arrest of two Romanian suspects in London linked to the stabbing of British-Iranian journalist Pouria Zeraati. This event highlights concerns over Iran's influence and criminal activities abroad, pivotal in today's finance and security discussions.
Research Reports

Fetal and Neonatal Monitoring Market To Register High Revenue Growth At 6.9% CAGR During 2021-2027, Industry Analysis by Segment, Size, Share, Pricing, Product Revenue, Demand, Key Companies, Regional Statistic

Published by Coherent Market Insights

Posted on October 6, 2021

4 min read
Add as preferred source on Google

Fetal and Neonatal Monitoring Market Growth Analysis 2021-2027

Fetal and Neonatal Monitoring Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Fetal and Neonatal Monitoring Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.

To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/1319

Major Players In This Market Are: Becton, Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG & Co. KGAA, Cooper Surgical, Getinge AB, Natus Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh, Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation, Spacelabs Healthcare Inc., Smiths Medical, and Masimo.

Fetal and neonatal monitoring is a technique of monitoring your newborn’s heart and lungs before, during, and after he/she was born. Normally the mother passes all of her body functions to the baby via vaginal deliveries or breastfeeding. A monitor is inserted into the birth canal to detect any irregularities in breathing, heartbeat, or pumping. These monitors are also used in early detection of any problems associated with your unborn baby such as congenital heart disease, breathing difficulties, or infections.

Market Dynamics

High prevalence of congenital heart disease in infants is expected to propel growth of the fetal and neonatal monitoring market. For instance, according to the study, Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study (published in May 2018), the prevalence of congenital heart disease (CHD) was 10.13/1000 live births. Moreover, emergence of Covid-19 is also expected to aid in growth of the market. For instance, in July 2020, Koninklijke Philips N.V. launched Avalon CL Fetal and Maternal Pod and Patch capable of providing “continuous non-invasive monitoring” of important vital signs such as maternal heart rate, fetal heart rate, and uterine activity.

High rate of maternal mortality in emerging economies is expected to offer lucrative growth opportunities for players in the fetal and neonatal monitoring market. For instance, according to Maternal Mortality: 1990 to 2015 Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division, Sub-Saharan Africa recorded the highest ratio or maternal mortality, at 555 per 100, 000 live births, from 1990 to 2015. Moreover, the United Nations is focused on achieving the Sustainable Development Goals 2015 – 2030 global maternal mortality ratio target of less than 70 per 100 000 live births.

Among regions, North America is expected to witness significant growth in the fetal and neonatal monitoring market, owing to increasing preterm birth rate in the U.S. For instance, according to March of Dimes 2019 report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63% in 2015.

Buy This Premium Report Of Fetal and Neonatal Monitoring Market Report 2021 @ https://www.coherentmarketinsights.com/insight/buy-now/1319

In this study, the years considered to estimate the market size of Fetal and Neonatal Monitoring are as follows:

History Year: 2017-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2028

The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Fetal and Neonatal Monitoring Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Fetal and Neonatal Monitoring Market are also given.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

The post Fetal and Neonatal Monitoring Market To Register High Revenue Growth At 6.9% CAGR During 2021-2027, Industry Analysis by Segment, Size, Share, Pricing, Product Revenue, Demand, Key Companies, Regional Statistic appeared first on Gatorledger.

Key Takeaways

  • The market is projected to grow at a 6.9% CAGR from 2021 to 2027.
  • High prevalence of congenital heart disease boosts market growth.
  • North America is expected to see significant market growth.
  • COVID-19 has positively impacted market dynamics.
  • Key players include GE Healthcare and Siemens Healthcare GmbH.

Frequently Asked Questions

What is the main topic?
The article discusses the growth and dynamics of the Fetal and Neonatal Monitoring Market from 2021 to 2027.
Who are the key players in this market?
Key companies include GE Healthcare, Siemens Healthcare GmbH, and Koninklijke Philips N.V.
What factors are driving market growth?
High prevalence of congenital heart disease and impacts of COVID-19 are major growth drivers.

Related Articles